newsfilter
← Latest News
GlobeNewswire·

Amicus Therapeutics Announces Settlement of Galafold® (migalastat) Patent Litigation with Teva

PRINCETON, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (NASDAQ:FOLD) today announced that it has entered into a License Agreement (Agreement) with Teva Pharmaceuticals USA, Inc. and Teva